Related Experiment Video
Updated: May 24, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
TAK1 at the crossroads of multiple regulated cell death pathways: from molecular mechanisms to human diseases
Kun Huang1,2, Qi Zhang1,3,4, Hao Wan1
1Department of Human Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, China.
Abstract:
Regulated cell death (RCD), the form of cell death that can be genetically controlled by multiple signaling pathways, plays an important role in organogenesis, tissue remodeling, and maintenance of organism homeostasis and is closely associated with various human diseases. Transforming growth factor-beta-activated kinase 1 (TAK1) is a member of the serine/threonine protein kinase family, which can respond to different internal and external stimuli and participate in inflammatory and immune responses. Emerging evidence suggests that TAK1 is an important regulator at the crossroad of multiple RCD pathways, including apoptosis, necroptosis, pyroptosis, and PANoptosis. The regulation of TAK1 affects disease progression through multiple signaling pathways, and therapeutic strategies targeting TAK1 have been proposed for inflammatory diseases, central nervous system diseases, and cancers. In this review, we provide an overview of the downstream signaling pathways regulated by TAK1 and its binding proteins. Their critical regulatory roles in different forms of cell death are also summarized. In addition, we discuss the potential of targeting TAK1 in the treatment of human diseases, with a specific focus on neurological disorders and cancer.
Insights
Transforming growth factor-beta-activated kinase 1 (TAK1) regulates multiple cell death pathways, impacting diseases. Targeting TAK1 offers therapeutic potential for cancer and neurological disorders.
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- Regulated cell death (RCD) is crucial for homeostasis and implicated in diseases.
- Transforming growth factor-beta-activated kinase 1 (TAK1) is a key kinase in cellular signaling.
- TAK1 links various RCD pathways, including apoptosis, necroptosis, pyroptosis, and PANoptosis.
Purpose of the Study:
- To review TAK1's role in diverse regulated cell death pathways.
- To summarize TAK1's downstream signaling and binding proteins.
- To discuss therapeutic strategies targeting TAK1 for human diseases.
Main Methods:
- Literature review of studies on TAK1 and regulated cell death.
- Analysis of signaling pathways regulated by TAK1.
- Synthesis of evidence on TAK1's role in disease progression.
Main Results:
- TAK1 acts as a central regulator at the intersection of multiple RCD pathways.
- TAK1 influences inflammatory and immune responses.
- TAK1 dysregulation is linked to various human diseases, including cancer and neurological disorders.
Conclusions:
- TAK1 is a critical regulator of multiple cell death forms.
- Targeting TAK1 presents a promising therapeutic avenue for inflammatory diseases, CNS disorders, and cancers.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Regulation of the Unfolded Protein Response
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Caspases

